Pharma Journalist -

SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.…
Read More...

SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference. SMi Group is delighted to announce the return of the successful 3D Cell Culture…
Read More...

Rapid Dose Therapeutics Corp. a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland…
Read More...

Syndax Pharmaceuticals, Inc. announced that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and that the parties closed the exclusive worldwide collaboration and…
Read More...

Prestige BioPharma Ltd. and Dr. Reddy’s Laboratories Ltd. announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and…
Read More...

AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that the…
Read More...

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo…
Read More...

NeurOp, Inc., a clinical-stage biotechnology company focused on neurological and psychiatric disorders, announced that the U.S. Food and Drug Administration (FDA) has granted orphan…
Read More...

PacBio and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The…
Read More...